Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Retrieved March 10, 2026, from 16 For the majority of the period depicted in Figure 2, chronic weight management was the sole approved indication for Wegovy, Zepbound, and Saxenda
The heart rate increase is progressive, typically adding 1 to 2 beats per minute with each dose escalation step
For best results, use LCLT as part of a comprehensive approach that includes a balanced diet, regular exercise, and a caloric deficit
Most of my patients in their forties, fifties, and sixties still have the structural materials available
By delving into these aspects, we aim to provide insights and strategies that can help optimize the weight loss experience for those using semaglutide